P

Inventor

BAN HITOSHI

JP41 patents
⚠️ This page may combine multiple inventors who share the name “BAN HITOSHI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SUMITOMO PHARMA CO LTD

17 patents
US11911466B2Feb 27, 2024

Substituted pyrimidines as vaccine adjuvants

SUMITOMO PHARMA CO LTD1 citations72
US11759509B2Sep 19, 2023

WT1 antigen peptide conjugate vaccine

SUMITOMO PHARMA CO LTD2 citations72
US11911381B2Feb 27, 2024

Optically active azabicyclo ring derivative

SUMITOMO PHARMA CO LTD1 citations71
US11795195B2Oct 24, 2023

Antibody-drug conjugates including hemiasterlin derivative

SUMITOMO PHARMA CO LTD2 citations71
US11564920B2Jan 31, 2023

5-heteroaryl-1H-pyrazol-3-amine derivative

SUMITOMO PHARMA CO LTD2 citations70
US12440560B2Oct 14, 2025

Substituted pyrimidines as vaccine adjuvants

SUMITOMO PHARMA CO LTD0 citations62
US12263167B2Apr 1, 2025

Optically active azabicyclo ring derivative

SUMITOMO PHARMA CO LTD0 citations60
US12398149B2Aug 26, 2025

Dihydrochromene derivatives

SUMITOMO PHARMA CO LTD0 citations59
US11661397B2May 30, 2023

1,4-disubstituted imidazole derivative

SUMITOMO PHARMA CO LTD0 citations59
US11639357B2May 2, 2023

Dihydrochromene derivatives

SUMITOMO PHARMA CO LTD0 citations59
US12559487B2Feb 24, 2026

Crosslinked optically active secondary amine derivative

SUMITOMO PHARMA CO LTD0 citations51
US12383608B2Aug 12, 2025

WT1 helper peptides and combinations of WT1 helper peptide and conjugate of cancer antigen peptides

SUMITOMO PHARMA CO LTD0 citations51
US12178879B2Dec 31, 2024

Hemiasterlin derivative and antibody-drug conjugate thereof

SUMITOMO PHARMA CO LTD0 citations51
US12018093B2Jun 25, 2024

Hemiasterlin derivatives and antibody-drug conjugates including same

SUMITOMO PHARMA CO LTD0 citations51
US12410154B2Sep 9, 2025

5-heteroaryl-1H-pyrazol-3-amine derivative

SUMITOMO PHARMA CO LTD0 citations49
US11434472B2Sep 6, 2022

Agent for removing undifferentiated iPS cells

SUMITOMO PHARMA CO LTD0 citations44
US12427192B2Sep 30, 2025

Water soluble adjuvant and composition containing same

SUMITOMO PHARMA CO LTD0 citations41

SUMITOMO DAINIPPON PHARMA CO LTD

14 patents
US9248173B2Feb 2, 2016

WT1 antigen peptide conjugate vaccine

SUMITOMO DAINIPPON PHARMA CO LTD14 citations92
US9181302B2Nov 10, 2015

WT1 antigen peptide conjugate vaccine

SUMITOMO DAINIPPON PHARMA CO LTD17 citations92
US10632192B2Apr 28, 2020

Pyrimidine compounds and their use as vaccine adjuvants

SUMITOMO DAINIPPON PHARMA CO LTD6 citations84
US11369605B2Jun 28, 2022

Optically active azabicyclo ring derivative

SUMITOMO DAINIPPON PHARMA CO LTD5 citations82
US9828362B2Nov 28, 2017

1,4-disubstituted imidazole derivative

SUMITOMO DAINIPPON PHARMA CO LTD5 citations80
US11325921B2May 10, 2022

Optically active crosslinked cyclic secondary amine derivative

SUMITOMO DAINIPPON PHARMA CO LTD2 citations72
US10815241B2Oct 27, 2020

Optically active azabicyclo ring derivative

SUMITOMO DAINIPPON PHARMA CO LTD4 citations71
US10807993B2Oct 20, 2020

Dihydrochromene derivatives

SUMITOMO DAINIPPON PHARMA CO LTD3 citations70
US11266738B2Mar 8, 2022

Substituted pyrimidines as vaccine adjuvants

SUMITOMO DAINIPPON PHARMA CO LTD0 citations62
US10588952B2Mar 17, 2020

Conjugate vaccine using trimming function of ERAP1

SUMITOMO DAINIPPON PHARMA CO LTD2 citations62
US10807945B2Oct 20, 2020

1,4-disubstituted imidazole derivative

SUMITOMO DAINIPPON PHARMA CO LTD1 citations59
US10898469B2Jan 26, 2021

Imidazolylamide derivative

SUMITOMO DAINIPPON PHARMA CO LTD0 citations44
US10294237B2May 21, 2019

Bicyclic heterocyclic amide derivative

SUMITOMO DAINIPPON PHARMA CO LTD0 citations39
US10597397B2Mar 24, 2020

Adenine conjugate compounds and their use as vaccine adjuvants

SUMITOMO DAINIPPON PHARMA CO LTD0 citations36

BOSTON BIOMEDICAL INC

3 patents

TOYODA AUTOMATIC LOOM WORKS

2 patents

SUMITOMO PHARMA

2 patents

SUMITOMO DAINIPPON PHARMA ONCOLOGY INC

1 patent

BARBAS III CARLOS F

1 patent

SUMITOMO PHARMA ONCOLOGY INC

1 patent